SPARC - MACD CROSSOVER 📊 Script: SPARC (SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED)
📊 Nifty50 Stock: NO
📊 Sectoral Index: NIFTY PHARMA
📊 Sector: Healthcare
📊 Industry: Pharmaceuticals & Biotechnology
Key highlights: 💡⚡
📈 Script is trading at upper band of BB and giving Breakout.
📈 MACD is giving crossover.
📈 Crossover in Double Moving Averages.
📈 Right now RSI is around 73.
⏱️ C.M.P 📑💰- 241
🟢 Target 🎯🏆 - 280
⚠️ Stoploss ☠️🚫 - 226
⚠️ Important: Always maintain your Risk & Reward Ratio.
✅Like and follow to never miss a new idea!✅
Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes.
Eat🍜 Sleep😴 TradingView📈 Repeat 🔁
Happy learning with trading. Cheers!🥂
SPARC trade ideas
SPARCSpotted this one late, the chart shows weekly breakout, if any chances of retracement and you get it in 230-235, you can long it with stop loss of 215.
************************************************************************************************************************************************
Hi all,
Its pleasure to have you all here.
I have started putting these charts as a contribution from my side to all people who are new to business, as I had to struggle a lot without any sources at disposal. So please consider this a just small contribution from my side.
Few Honest Disclosures:
1. Any idea shared is my personal view, its not a recommendation, neither any kind of paid propaganda, so please
do your bit of research.
2. Ideas shared does not mean that I trade all or have position in them, this is just a helping hand to all.
3. I expect no comments or like nor any negativity, as I said its just a small helping hand from my side, please plan your risk and trade as per your capacity.
4. To trade in Cash, options or futures is your sole choice and your own risk
5. I am no expert in Tech Indicators, I believe in support resistance and trendline theory, you may use this as a supplement theory for better results.
6. I work for my own living, this is a hobby which I do sincerely to help anyone who might come across my charts.
***********************************************************************************************************************************************